Leo Bonifacio

Leo Bonifacio is an experienced biopharmaceutical professional currently serving as the Director of Business Development at Edesa Biotech, Inc. since October 2019, where the focus is on clinical-stage drugs for inflammatory and immune-related diseases. In addition to this role, Leo is involved in Corporate Development at Cora Therapeutics and previously held a position as Business Development Manager at Exzell Pharma, managing key initiatives for product portfolios. Previous experience includes Strategy and Business Development Manager at Synaptive Medical and various roles at Shift Health and Opalux Inc., encompassing business assessment and technical development. Leo holds a PhD in Chemistry from the University of Toronto, a Certificate in Business Administration from Schulich School of Business, and both a Master's and Bachelor's degree in Chemistry from the Universidade de São Paulo.